Product Name |
Mono-O-acetyl Fingolimod |
Alternate Names |
Fingolimod Impurities, Impurities of Fingolimod |
CAT No. |
CS-O-15957
|
CAS No. |
1807973-92-7 |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
349.51 g/mol |
Mol. For. |
C₂₁H₃₅NO₃
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Fingolimod |
Therapeutic |
Immunosuppressants |
Smileys |
NC(CO)(CCC1=CC=C(C=C1)CCCCCCCC)COC(C)=O |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Mono-O-acetyl Fingolimod, also known as ponesimod, is a selective sphingosine 1-phosphate receptor 1 (S1P1) modulator used as an immunomodulatory drug. It is primarily used for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.
Mono-O-acetyl Fingolimod works by binding to S1P1 receptors in lymphoid tissues, thereby preventing the egress of lymphocytes from these tissues into the circulation. By doing so, it reduces the number of lymphocytes in the bloodstream, which may contribute to the reduction in MS disease activity.
The chemical formula of Mono-O-acetyl Fingolimod is C23H32FNO3, and its molecular weight is 399.5 g/mol. It is administered orally as a tablet and has a half-life of approximately 32 hours. It is metabolized in the liver and excreted primarily in the feces.
The most common side effects of Mono-O-acetyl Fingolimod include headache, diarrhea, nausea, back pain, and elevated liver enzymes. It is contraindicated in patients with severe active infections, certain heart conditions, and those taking certain medications.
In summary, Mono-O-acetyl Fingolimod is a useful immunomodulatory drug used for the treatment of relapsing forms of MS. It works by binding to S1P1 receptors in lymphoid tissues, reducing the number of lymphocytes in the bloodstream, and therefore reducing MS disease activity.